Featured Research

from universities, journals, and other organizations

Tissue Regeneration Operates Differently Than Expected

Date:
August 4, 2005
Source:
Max-Planck-Gesellschaft
Summary:
Embryonic and adult stem cells are thought to become a chance for new therapeutic approaches, making the regeneration of damaged tissue and organs possible. An increasing line of indications suggests that these cells may have the potential to repair damaged tissue.

Evidence of the fusion of stem and muscle cells. In this experiment, human mesenchymal stem cells, which in this case produce a green fluorescent dye, are being cultivated together with muscle cells derived from mice. The picture shows the result of the fusion. In the fused cells, there is evidence of both the stem cell (in green dye), and typical muscle cell protein (red and partially orange because of the overlap of the two colours). The product of the fusion contains both, cell nuclei from the mouse (in blue) and from the human cell (indicated by the arrow). These nuclei can be distinguished by size, and the weak blue-colouring of the mouse nuclei.
Credit: Image : Max Planck Institute for Heart and Lung Research

Embryonic and adult stem cells are thought to become a chance fornew therapeutic approaches, making the regeneration of damaged tissueand organs possible. An increasing line of indications suggests thatthese cells may have the potential to repair damaged tissue.

There is disagreement, however, about the mechanism on which repairprocesses are based. Scientists from the Max Planck Institute for Heartand Lung Research in Bad Nauheim, Germany, in co-operation withcolleagues from Martin Luther University in Halle-Wittenberg, have nowshown that skeletal muscle tissue can fuse with adult stem cells, via amechanism based on the participation of mediators which are generallyinvolved in immune cell activation. Although being unable totransdifferentiate into completely functional muscle cells, they areintegrated into the tissue complex by fusing with differentiated tissuecells. In contrast, in the heart muscle tissue the mechanism seems tobe different from this. The scientists in Bad Nauheim conclude fromtheir study that adult stem cells are involved in tissue repairprocesses in a paracrine way by delivering mediating factors ratherthan by simply becoming components of the regenerating organ. (Genes& Development, August 2005).

Stem cells are fully unspecialised cells which can develop into allkinds of cell types. Embryonic stem cells provide the origin of adeveloping organ, during the growth of an embryo. For example,mesenchymal cells -- stem cells from embryonic connective tissue --transform themselves during embryogenesis into muscle cells, under theinfluence of certain growth factors.

Other stem cells -- adult stem cells -- play an important rolethroughout an organism's life. For example, bone marrow stem cellsprovide for the replenishment of short-lived blood cells. Adult stemcells can be found locally in various tissues and organs, and we havepresumed that they are participating in the repair and maintenance oforgan functions.

The controversial idea is that adult stem cells have thepotential for transdifferentiation; in other words, that they are ableto transmutate from one type of organ cell to another. If that is thecase, bone marrow cells would be able to change into lots of differentkinds of tissue cells -- for example, skeletal muscle cells.

Scientists led by Thomas Braun, Director of the Max PlanckInstitute for Heart and Lung Research, have discovered by a number ofdifferent experimental approaches that mesenchymal stem cells only showa rudimentarily developed potential for transdifferentiation processes.All cases in which functional skeletal muscle cells arose frommesenchymal stem cells were based on the fusion of stem cells withalready differentiated muscle cells.

Although, like the researchers from Bad Nauheim show,cultivated mesenchymal stem cells are able to express a number ofheart- and skeletal muscle specific genes and undergo some morphologicchanges, after they are co-cultured with growth-factor producing feedercells, finally they did not become entirely functional muscle cells.

Fully-functional muscle cells only developed after themesenchymal stem cells were cultivated together with skeletal or heartmuscle cells. This was indicated by the green fluorescence of musclecells derived from the fusion with a stem cell which before had beenlabelled with the green dye. In contrast, no green fluorescing musclecells became evident when stem and muscle cells were spatiallyseparated by a membrane between both cell types. The researchersconclude that this experiments proofs that cell fusion of mesenchymalstem cells and muscle cell but not their transdifferentiation forms thebasis for the regeneration mechanism. Additional experiments werefocussing on the molecular mechanism underlying the cell fusionprocess. In these investigations, so-called "chimeric" mouse embryoswere produced from mesenchymal stem cells and several mouse mutants:Obviously, the stem cells are recruiting the IL-4/NFAT signallingpathway which also is involved in the activation of T-lymphocytesduring immune response.

From the findings presented by Thomas Braun and hiscollaborators some important consequences for the use of adult stemcells in possible therapeutic approaches could arise, since theycontradict the predominant opinion that bone marrow-derived or localstem cells are involved in the regeneration of heart and skeletalmusculature by transdifferentiating into muscle cells. By fusing withthe cells of the regenerating tissue these cells rather seem to onlysimulate such a transdifferentiation mechanism. This has majorimplications for the prospects of stem cell therapies targeting on theregeneration of skeletal or heart musculature.


Story Source:

The above story is based on materials provided by Max-Planck-Gesellschaft. Note: Materials may be edited for content and length.


Cite This Page:

Max-Planck-Gesellschaft. "Tissue Regeneration Operates Differently Than Expected." ScienceDaily. ScienceDaily, 4 August 2005. <www.sciencedaily.com/releases/2005/08/050804123045.htm>.
Max-Planck-Gesellschaft. (2005, August 4). Tissue Regeneration Operates Differently Than Expected. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/08/050804123045.htm
Max-Planck-Gesellschaft. "Tissue Regeneration Operates Differently Than Expected." ScienceDaily. www.sciencedaily.com/releases/2005/08/050804123045.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins